Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of pregabalin and duloxetine on pain, cognitive function, sleep, and quality of life in painful diabetic peripheral neurop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: KRKA | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 4 | Status: TERMINATED